A detailed history of Fox Run Management, L.L.C. transactions in Johnson & Johnson stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 7,673 shares of JNJ stock, worth $1.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
7,673
Previous 5,233 46.63%
Holding current value
$1.2 Million
Previous $827,000 35.55%
% of portfolio
0.22%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $352,287 - $384,983
2,440 Added 46.63%
7,673 $1.12 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $812,266 - $851,618
5,233 New
5,233 $827,000
Q3 2023

Nov 07, 2023

BUY
$155.75 - $174.48 $788,718 - $883,566
5,064 New
5,064 $788,000
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $219,992 - $243,301
-1,308 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $375,108 - $425,987
-2,372 Reduced 64.46%
1,308 $232,000
Q4 2021

Feb 09, 2022

BUY
$155.93 - $173.01 $573,822 - $636,676
3,680 New
3,680 $630,000
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $464,992 - $534,066
-3,647 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$126.95 - $142.14 $462,986 - $518,384
3,647 New
3,647 $472,000
Q1 2019

Oct 17, 2019

SELL
$125.72 - $139.79 $560,585 - $623,323
-4,459 Closed
0 $0
Q4 2018

Jan 15, 2019

SELL
$122.84 - $147.84 $177,503 - $213,628
-1,445 Reduced 24.47%
4,459 $575,000
Q3 2018

Oct 05, 2018

SELL
$121.58 - $142.88 $181,397 - $213,176
-1,492 Reduced 20.17%
5,904 $816,000
Q2 2018

Jul 17, 2018

BUY
$119.4 - $131.76 $883,082 - $974,496
7,396 New
7,396 $897,000
Q1 2018

Apr 17, 2018

SELL
$125.1 - $148.14 $705,814 - $835,805
-5,642 Closed
0 $0
Q4 2017

Jan 18, 2018

SELL
$131.22 - $143.62 $86,342 - $94,501
-658 Reduced 10.44%
5,642 $788,000
Q3 2017

Oct 23, 2017

BUY
$129.47 - $135.38 $815,661 - $852,894
6,300
6,300 $819,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.